2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Targeted Therapy in mNSCLC: Is Trastuzumab Deruxtecan a Promising New Therapy for HER2+? How Beneficial Is Erlotinib + Bevacizumab in EGFR+ Disease?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ryan Gentzler
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ryan Gentzler
76 views
August 24, 2020
Login to view comments.
Click here to Login
Lung